Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D Feldman

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
International Journal of Geriatric Psychiatry|February 6, 2004
Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's diseasePeter Paul De Deyn, Manuel Martín Carrasco, Walter Deberdt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2002
Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementiaKarena M Meehan, Huei Wang, Stacy R David, et al.
Journal of the American Medical Directors Association|January 7, 2004
Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United StatesPeter D Feldman, Linda K Hay, Walter Deberdt, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 9, 2005
Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementiaWalter G Deberdt, Maurice W Dysken, Stephen A Rappaport, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 23, 2003
Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophreniaIstvan Bitter, Martin R K Dossenbach, Shlomo Brook, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 2, 2004
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser aloneMauricio Tohen, K N Roy Chengappa, Trisha Suppes, et al.
Archives of General Psychiatry|January 12, 2002
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapyMauricio Tohen, K N Roy Chengappa, Trisha Suppes, et al.
Journal of Child and Adolescent Psychopharmacology|November 6, 2007
Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatmentThomas J Spencer, Christopher J Kratochvil, R Bart Sangal, et al.
Journal of Attention Disorders|October 16, 2007
Atomoxetine treatment of ADHD in children with comorbid Tourette syndromeThomas J Spencer, F Randy Sallee, Donald L Gilbert, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
International Journal of Geriatric Psychiatry|February 6, 2004
Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's diseasePeter Paul De Deyn, Manuel Martín Carrasco, Walter Deberdt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2002
Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementiaKarena M Meehan, Huei Wang, Stacy R David, et al.
Journal of the American Medical Directors Association|January 7, 2004
Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United StatesPeter D Feldman, Linda K Hay, Walter Deberdt, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 9, 2005
Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementiaWalter G Deberdt, Maurice W Dysken, Stephen A Rappaport, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 23, 2003
Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophreniaIstvan Bitter, Martin R K Dossenbach, Shlomo Brook, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 2, 2004
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser aloneMauricio Tohen, K N Roy Chengappa, Trisha Suppes, et al.
Archives of General Psychiatry|January 12, 2002
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapyMauricio Tohen, K N Roy Chengappa, Trisha Suppes, et al.
Journal of Child and Adolescent Psychopharmacology|November 6, 2007
Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatmentThomas J Spencer, Christopher J Kratochvil, R Bart Sangal, et al.
Journal of Attention Disorders|October 16, 2007
Atomoxetine treatment of ADHD in children with comorbid Tourette syndromeThomas J Spencer, F Randy Sallee, Donald L Gilbert, et al.
Pageof 3